Use for budesonide and formoterol

Details Use for budesonide and formoterol Use for budesonide and formoterol

2011-03-01

2011-03-01

Kim, Jennifer (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S171000, C424S045000

Reexamination Certificate

active

07897646

ABSTRACT:
The invention provides the use of formoterol and budesonide in the treatment of chronic obstructive pulmonary disease.

REFERENCES:
patent: 5250286 (1993-10-01), Skupin
patent: 5674860 (1997-10-01), Carling et al.
patent: 5684199 (1997-11-01), Francotte
patent: 5795564 (1998-08-01), Aberg et al.
patent: 5972919 (1999-10-01), Carling et al.
patent: 5996576 (1999-12-01), Yule
patent: 6030604 (2000-02-01), Trofast
patent: 6277862 (2001-08-01), Giardina et al.
patent: 6598603 (2003-07-01), Andersson et al.
patent: 2123909 (1993-06-01), None
patent: 2356145 (1993-06-01), None
patent: 0 416 950 (1991-03-01), None
patent: 0 416 951 (1991-03-01), None
patent: 0 523 638 (1993-01-01), None
patent: 1085877 (1999-12-01), None
patent: 1 014 993 (2000-07-01), None
patent: 0613371 (2002-03-01), None
patent: 9703407-8 (1998-09-01), None
patent: WO 92/11280 (1992-07-01), None
patent: WO 97/11783 (1997-04-01), None
patent: WO 98/15280 (1998-04-01), None
patent: WO 98/31351 (1998-07-01), None
patent: WO 99/00134 (1999-01-01), None
patent: WO 99/64014 (1999-12-01), None
patent: WO 00/30608 (2000-06-01), None
patent: WO 00/35441 (2000-06-01), None
patent: WO 00/53188 (2000-09-01), None
Cazzola et al. “Effect of salmeterol and formoterol in patients with chronic obsructive pulmonary disease” Pulmonary Pharmacology 1994, 7/2 p. 103-107.
Nederlands Tijdschrift voor Geneeskunde “Opportunistic lung infection in patients with chronic obstructive pulmonary disease” 1996 140/2 pp. 94-98 ISSN: 0028-2162 CODEN:NETJAN.
Saunders Manual of Medicine Practice. Rakel 1996.
Renkema et al. “Effects of long-term treatment with corticosteroids in COPD.” Chest, 1996, vol. 109, No. 5. abstract AN 1996:325104.
The Merck Manual, sixteenth Edition, 1992, pp. 658-659.
Opportunistic Lung Infections in Patients with Chronic Obstructive Pulmonary Disease- A Side Effect of Inhalation Corticosteroids? Smeenk et al. Nederlands Tijdschrift Geneeskunde vol. 13, Jan. Issue 140 (2) 1996 pp. 94-98. Full English translation.
Barnes et al., “Chronic obstructive pulmonary disease: molecular and cellular mechanisms,”Eur. Respir. J. 22:672-688 (2003).
Buist, “Definitions,” inAsthma and Chronic Obstructive Pulmonary Disease, Barnes et al. eds.,Acad. Press, pp. 3-6 (2002).
Calverley et al., “Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease,”Eur. Respir. J. 22:912-919 (2003).
Rabe, “Combination therapy for chronic obstructive pulmonary disease; one size fits all?”Eur. Respir. J. 22:874-875 (2003).
“Analysis of DIN-LINK Co-prescription Records for Inhaled Steroids and Long-Acting Beta Agonists in the Period 1990-1998” pp. 1-2, appendices A and B; published 1990-1998.
Pearson et al., “British Thoracic Society Guidelines for Treatment of COPD”Thorax52 (Suppl. 5):S1-S28 (1997).
Jackevicius et al., “Prehospitalization Inhaled Cortiscoteroid Use in Patients With COPD or Asthma”Chest111:296-302 (1997).
“Foradil”MIMS-Monthly Index of Medical SpecialtiesJan. 10 (1996).
Pauwels, “COPD: The Scope of the Problem in Europe”Chest117:332D-335S (2000).
Roberts et al., “Which patients are prescribed inhaled anti-asthma drugs?”Thorax49(11):1090-1095 (1994).
Van Andel et al., “Analysis of Inhaled Corticosteroid and Oral Theophylline Use Among Patients With Stable COPD from 1987 to 1995”Chest115:703-707 (1999).
Compendium Suisse des Medicaments, 15 th Ed. 1997/1998, Ed. Grand Public, compiled Jun. 1996, pp. 2-3,419-420,866 (in French).
Compendium Suisse des Medicaments, 18th Ed. 1997, compiled Jun. 1996, pp. 5,849-851 and 1635-1636 (in French).
“American Thoracic Society: Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease,”Am. J. Respir. Care Med. 152:S77-S121 (1995).
“Atemstillstand”Pschyrembel Klinisches Wörtebuch(2002) (in German).
Auffarth et al., “Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease”Thorax46:372-377 (1991).
Barnes, “Inhaled steroids in COPD”The Lancet351:766-767 (1998).
Basic Reference Manual, vol. 1, revised ed. of 1988, issued by IMS International.
“Bronchodilators and anti-inflammatories,”Monthly Index of Medical Specialities(MIMS) 242-256 (Sep. 1997).
Boyd et al., “An Evaluation of Salmeterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD),”Eur. Resp. J. 10:815-821 (1997).
Burge et al. “Randomised, double blind, placebo controlled study of fluticasone propionate in patents with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial,”British Med. J. 320:1297-1303 (2000).
Davies et al., “Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease,” Q. J. Med. 92:395-400 (1999).
“Disorders of the Airways,”Current Medical Diagnosis and Treatment 199736thed. pp. 241-255, Stamford, CT: Appleton and Lange (1997).
Dompeling et al., “Slowing the deterioration of Asthma and Chronic Obstructive Pulmonary Disease Observed during Bronchodilator Therapy by Adding Inhaled Corticosteroids,”Ann. Intern. Med. 118(10):770-778 (1993).
Engel et al., “A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis”Eur. Respir. J. 2:935-939 (1989).
Fabbri et al., “Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update”Eur. Respir. J. 22:1-2 (2003).
Flenley, “Chronic Obstructive Pulmonary Disease,”Disease-A-Month34:549-599 (1988).
“Foradil”Compendium Suisse des Medicaments, Supplement 1a pp. 7-8 (1991) (in French).
“Foradil,”Compendium Suisse des Medicaments, 15th Ed. 1997/1998, Ed. Grand Public, compiled Jun. 1996, pp. 419-420, 866 (in French).
“Foradil,”Compendium Suisse des Medicaments, 18th Ed. 1997, compiled Jun. 1996, pp. 849-850 and 1635 (in French).
“Foradil,” Patient information leaflet, published by IKS, Switzerland (Dec. 1990) (in French).
Gibson et al.,Respiratory MedicineTable of contents (2002).
“GOLD: Global Initiative for Chronic Obstructive Lung Disease,” Executive Summary; National Institutes of Health, National Heart Lung and Blood Institute, NIH Publication No. 2701A, pp. 1-30 (Mar. 2001).
“GOLD: Global Initiative for Chronic Obstructive Lung Disease; Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease,” based on Apr. 1998 NHLBI/WHO Workshop, pp. 1-100 (2004 Update).
Jeffery “Structural and inflammatory changes in COPD: a comparison with asthma”Thorax53:129-136 (1998).
Keatings et al., “Effects of Inhaled and Oral Glucocorticoids on Inflammatory Indices in Asthma and COPD”Am. J. Respic. Crit. Care Med. 155:542-548 (1997).
Kerstjens et al., “A Comparison of Bronchodilator Therapy with or without Inhaled Corticosteroid Therapy for Obstructive Airway Disease,”New Eng. J. Med. 327:1413-1419 (1992).
Leff et al., “Theraputic Regimens in Chronic Obstructive Pulmonary Disease,”Pulmon. Crit. Care Pharmacol. Therapeut. Ch. 86:837-844 (1996).
Niewoehner et al., “Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease”New Eng. J. Med. 340(25):1941-1947 (1999).
Norman, “COPD: New Developments and Therapeutic Opportunities”Drug News Perpect. 11(7):431-437 (1988).
Pauwels et al., “Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking”N. Eng. J. Med. 340:1948-1953 (1999).
Postma, “Inhaled therapy in COPD: what are the benefits?”Respiratory Medicine85:447-449 (1991).
“Pulmicort” ABPI Data Sheet Compendium, p. 14

Affiliated with

Also associated with

Rating

Use for budesonide and formoterol does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use for budesonide and formoterol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use for budesonide and formoterol will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2627120